These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23625911)

  • 1. Metoprolol and diltiazem ameliorate ziprasidone-induced prolonged corrected QT interval in rats.
    Erbas O; Yilmaz M
    Toxicol Ind Health; 2015 Dec; 31(12):1152-7. PubMed ID: 23625911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-Four-Hour Measures of Heart Rate-Corrected QT Interval, Peak-to-End of the T-Wave, and Peak-to-End of the T-Wave/Corrected QT Interval Ratio During Antipsychotic Treatment.
    Tümüklü MN; Tümüklü MM; Nesterenko V; Jayathilake K; Beasley CM; Meltzer HY
    J Clin Psychopharmacol; 2019; 39(2):100-107. PubMed ID: 30707117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
    Camm AJ; Karayal ON; Meltzer H; Kolluri S; O'Gorman C; Miceli J; Tensfeldt T; Kane JM
    CNS Drugs; 2012 Apr; 26(4):351-65. PubMed ID: 22452529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT interval duration and dispersion in children and adolescents treated with ziprasidone.
    Correll CU; Lops JD; Figen V; Malhotra AK; Kane JM; Manu P
    J Clin Psychiatry; 2011 Jun; 72(6):854-60. PubMed ID: 21457682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
    Taylor D
    CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
    Potkin SG; Preskorn S; Hochfeld M; Meng X
    J Clin Psychopharmacol; 2013 Feb; 33(1):3-10. PubMed ID: 23277250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano R; O'Gorman C; Harrigan RH
    Pharmacotherapy; 2010 Feb; 30(2):127-35. PubMed ID: 20099987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
    Greco KE; Tune LE; Brown FW; Van Horn WA
    J Clin Psychiatry; 2005 Jul; 66(7):928-9. PubMed ID: 16013910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
    Kelly DL; Love RC
    Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose ziprasidone associated with QT interval prolongation.
    Witsil JC; Zell-Kanter M; Mycyk MB
    Am J Emerg Med; 2012 Jun; 30(5):837.e1-2. PubMed ID: 21641143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.
    Mischoulon D; Shelton RC; Baer L; Bobo WV; Curren L; Fava M; Papakostas GI
    J Clin Psychiatry; 2017 Apr; 78(4):449-455. PubMed ID: 27835715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of diltiazem and metoprolol in QTc prolongation due to amitriptyline intoxication.
    Basol N; Erbas O
    Hum Exp Toxicol; 2016 Jan; 35(1):29-34. PubMed ID: 25724422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prophylactic Effects of Metoprolol, Diltiazem, and Pilocarpine on Hypoglycemia-Induced Prolongation of QT Interval.
    Cagiltay E; Pouwels S; Erbas O; Taskiran D; Kalkanli Tas S; Aslan I
    Cureus; 2021 Mar; 13(3):e14058. PubMed ID: 33898141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
    Bentley ML; Biscardi FH; Butcher C; Levitov A
    Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
    [No Abstract]   [Full Text] [Related]  

  • 18. Diltiazem versus metoprolol for the management of atrial fibrillation: A systematic review and meta-analysis.
    Jafri SH; Xu J; Warsi I; Cerecedo-Lopez CD
    Am J Emerg Med; 2021 Oct; 48():323-327. PubMed ID: 34274577
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of Pazopanib-Induced Prolonged Cardiac Repolarization and Proarrhythmic Effects.
    Akman T; Erbas O; Akman L; Yilmaz AU
    Arq Bras Cardiol; 2014 Nov; 103(5):403-409. PubMed ID: 25229355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No significant QTc interval changes with high-dose ziprasidone: a case series.
    Levy WO; Robichaux-Keene NR; Nunez C
    J Psychiatr Pract; 2004 Jul; 10(4):227-32. PubMed ID: 15552544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.